Advertisement

Cancer Causes & Control

, 20:1671 | Cite as

Trends in adult leukemia incidence and survival in Denmark, 1943–2003

  • Lau Caspar ThygesenEmail author
  • Ove Juul Nielsen
  • Christoffer Johansen
Original paper

Abstract

The etiology of leukemia is largely unknown. Ecological data indicating trends in incidence and survival can provide information about changes in risk factors, can reflect underlying changes in diagnostic classification, and can measure therapeutic advances. From the records of the Danish Cancer Registry with registration starting from 1943, we calculated age-specific, period-specific, and age-standardized (world standard) incidence rates of chronic lymphoid leukemia (CLL), acute lymphoid leukemia (ALL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML) for persons above the age of 18. Kaplan–Meier survival curves and median survival times were calculated. Between 1943 and 2003, there were 26,036 cases of leukemia reported. The age-specific incidence rates of CLL, CML, and AML were higher for older men and women, while the incidence rates of ALL by age were more homogeneous. The age-standardized incidence rates during the study period increased for CLL and AML, increased less strongly for ALL, and decreased for CML in both men and women, although the incidence rates for women were almost always lower. Patients with CLL had the longest survival time in all age groups. The median survival time increased for all leukemia subtypes throughout the period of study most pronounced for CLL since 1950 and CML since 1990.

Keywords

Lymphoid malignancies Myeloid leukemia Leukemia Incidence Survival Denmark 

Notes

Acknowledgments

This study was partly supported by Novartis Denmark.

References

  1. 1.
    Petridou E, Trichopoulos D (2002) Leukemias. In: Adami H-O, Hunter D, Trichopoulos D (eds) Textbook in cancer epidemiology. Oxford University Press, Oxford, pp 556–572Google Scholar
  2. 2.
    The National Board of Health HS (2003) Cancer incidence in Danmark 1999. National Board of Health, KøbenhavnGoogle Scholar
  3. 3.
    Blair V, Birch JM (1994) Patterns and temporal trends in the incidence of malignant disease in children: I. Leukaemia and lymphoma. Eur J Cancer 30A:1490–1498CrossRefPubMedGoogle Scholar
  4. 4.
    Kwiatkowski A (1994) Trends in the incidence of leukaemia in Poland, 1963–90: an epidemiologic study. Eur J Cancer Prev 3:277–283CrossRefPubMedGoogle Scholar
  5. 5.
    Groves FD, Linet MS, Devesa SS (1995) Patterns of occurrence of the leukaemias. Eur J Cancer 31A:941–949CrossRefPubMedGoogle Scholar
  6. 6.
    Kaatsch P, Haaf G, Michaelis J (1995) Childhood malignancies in Germany—methods and results of a nationwide registry. Eur J Cancer 31A:993–999CrossRefPubMedGoogle Scholar
  7. 7.
    Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL (1996) Trends in cancer incidence among children in the US. Cancer 78:532–541CrossRefPubMedGoogle Scholar
  8. 8.
    McNally RJ, Rowland D, Roman E, Cartwright RA (1997) Age and sex distributions of hematological malignancies in the UK. Hematol Oncol 15:173–189CrossRefPubMedGoogle Scholar
  9. 9.
    Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK (1998) Cancer incidence and mortality, 1973–1995: a report card for the US. Cancer 82:1197–1207CrossRefPubMedGoogle Scholar
  10. 10.
    Linet MS, Ries LA, Smith MA, Tarone RE, Devesa SS (1999) Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 91:1051–1058CrossRefPubMedGoogle Scholar
  11. 11.
    McNally RJ, Roman E, Cartwright RA (1999) Leukemias and lymphomas: time trends in the UK, 1984–93. Cancer Causes Control 10:35–42CrossRefPubMedGoogle Scholar
  12. 12.
    McNally RJ, Birch JM, Taylor GM, Eden OB (2000) Incidence of childhood precursor B-cell acute lymphoblastic leukaemia in north-west England. Lancet 356:485–486CrossRefPubMedGoogle Scholar
  13. 13.
    McNally RJ, Cairns DP, Eden OB, Kelsey AM, Taylor GM, Birch JM (2001) Examination of temporal trends in the incidence of childhood leukaemias and lymphomas provides aetiological clues. Leukemia 15:1612–1618CrossRefPubMedGoogle Scholar
  14. 14.
    Xie Y, Davies SM, Xiang Y, Robison LL, Ross JA (2003) Trends in leukemia incidence and survival in the United States (1973–1998). Cancer 97:2229–2235CrossRefPubMedGoogle Scholar
  15. 15.
    Yamamoto JF, Goodman MT (2008) Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002. Cancer Causes Control 19:379–390CrossRefPubMedGoogle Scholar
  16. 16.
    Roswall N, Olsen A, Christensen J, Rugbjerg K, Mellemkjaer L (2008) Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994–2003. Eur J Cancer 44:2058–2073CrossRefPubMedGoogle Scholar
  17. 17.
    Segi M (1960) Cancer mortality for selected sites in 24 countries (1950–57). Tohoku University School of Public Health, SendaiGoogle Scholar
  18. 18.
    Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M (2000) Age standardization of rates: a new WHO standard. World Health Organization. GPE Discussion Paper Series: No. 31Google Scholar
  19. 19.
    Clemmensen IH, Nedergaard KH, Storm HH (2006) Cancer in Denmark [in Danish]. FADL’s forlag, CopenhagenGoogle Scholar
  20. 20.
    Izraeli S, Rainis L, Hertzberg L, Smooha G, Birger Y (2007) Trisomy of chromosome 21 in leukemogenesis. Blood Cells Mol Dis 39:156–159CrossRefPubMedGoogle Scholar
  21. 21.
    Johansen C (2004) Electromagnetic fields and health effects—epidemiologic studies of cancer, diseases of the central nervous system and arrhythmia-related heart disease. Scand J Work Environ Health 30(Suppl 1):1–30PubMedGoogle Scholar
  22. 22.
    Jaffe ES, Harris NL, Stein H et al (2001) World Health Organization classification of tumors of haematopoietic and lymphoid tissues. IARC Press, LyonGoogle Scholar
  23. 23.
    Dogan A (2005) Modern histological classification of low grade B-cell lymphomas. Best Pract Res Clin Haematol 18:11–26CrossRefPubMedGoogle Scholar
  24. 24.
    Head DR (2002) Proposed changes in the definitions of acute myeloid leukemia and myelodysplastic syndrome: are they helpful? Curr Opin Oncol 14:19–23CrossRefPubMedGoogle Scholar
  25. 25.
    Aurran-Schleinitz T, Arnoulet C, Ivanov V et al (2008) Chronic lymphocytic leukaemia: current management. Rev Med Interne 29:424–435CrossRefPubMedGoogle Scholar
  26. 26.
    Moreno C, Montserrat E (2008) New prognostic markers in chronic lymphocytic leukemia. Blood Rev 22:211–219CrossRefPubMedGoogle Scholar
  27. 27.
    Larson S, Stock W (2008) Progress in the treatment of adults with acute lymphoblastic leukemia. Curr Opin Hematol 15:400–407CrossRefPubMedGoogle Scholar
  28. 28.
    Fausel C (2007) Targeted chronic myeloid leukemia therapy: seeking a cure. J Manag Care Pharm 13:8–12PubMedGoogle Scholar
  29. 29.
    Pinilla-Ibarz J, Bello C (2008) Modern approaches to treating chronic myelogenous leukemia. Curr Oncol Rep 10:365–371CrossRefPubMedGoogle Scholar
  30. 30.
    Ravandi F, Burnett AK, Agura ED, Kantarjian HM (2007) Progress in the treatment of acute myeloid leukemia. Cancer 110:1900–1910CrossRefPubMedGoogle Scholar
  31. 31.
    Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish cancer registry—history, content, quality and use. Dan Med Bull 44:535–539PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Lau Caspar Thygesen
    • 1
    • 2
    Email author
  • Ove Juul Nielsen
    • 3
  • Christoffer Johansen
    • 1
  1. 1.Institute of Cancer EpidemiologyDanish Cancer SocietyCopenhagenDenmark
  2. 2.National Institute of Public HealthUniversity of Southern DenmarkCopenhagenDenmark
  3. 3.Department of HematologyRigshospitalet University HospitalCopenhagenDenmark

Personalised recommendations